Skip to content

Xerothera, Inc.

Country not established

Devices
1

What Xerothera, Inc. makes

Xerothera, Inc. manufactures the Xerosyn, a device designed for transdermal drug delivery using iontophoresis technology to enhance absorption of topical medications through the skin.

The Xerosyn is classified as a Class II medical device under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Xerosyn Ref K233259

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Xerothera, Inc. have in the registry?

The registry currently lists 1 device for Xerothera, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Xerothera, Inc.'s devices?

Among its 1 most recently registered device, Xerothera, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Xerothera, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Xerothera, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Xerothera, Inc. in the registry?

The most recently registered devices listed for Xerothera, Inc. include Xerosyn.

Generated automatically from registry data and not verified by a human reviewer.